Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong
· Delayed Price · Currency is HKD 3.340
+0.240 (7.74%)
Mar 10, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Revenue
Hua Medicine (Shanghai) had revenue of 217.43M CNY in the half year ending June 30, 2025, with 209.16% growth. This brings the company's revenue in the last twelve months to 370.66M, up 240.24% year-over-year. In the year 2024, Hua Medicine (Shanghai) had annual revenue of 255.89M with 234.02% growth.
Revenue (ttm)
370.66M CNY
Revenue Growth
+240.24%
P/S Ratio
7.54
Revenue / Employee
1.30M CNY
Employees
285
Market Cap
3.06B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| VISEN Pharmaceuticals | 921.55K |
| Jacobson Pharma Corporation | 1.53B |
| Essex Bio-Technology | 1.72B |
| Golden Throat Holdings Group Company | 1.07B |
| JBM (Healthcare) | 812.98M |
| Edding Genor Group Holdings | 245.46M |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |
| China Shineway Pharmaceutical Group | 3.66B |